In addition, Mickler et al. [32] found that AG 1478, a specific inhibitor of EGFR phosphorylation, could inhibit EGF from entering cells but could not inhibit GE11, indicating that GE11-mediated cancer therapy does not cause side effects via mitogenic signaling. Here, EGFR is linked to cancer.